HONG KONG, March 04, 2019 (GLOBE NEWSWIRE) -- Dragon Jade International Limited (“Dragon Jade” or “the Company”) (OTCQX: DGJI), a provider of premier products and services, today announced the appointment of Dr. Dominic Man-Kit Lam as an independent director.
Dr. Dominic Man-Kit Lam has over 40 years of experience in biotechnology development, research, and education. He is currently Chief Scientific Consultant at Chaoda Modern Agriculture (Holdings) Ltd, Industrial Advisor at EQT Partners AB, Chairman of the Board and a Director at MacKay Life Sciences, Inc, non-executive Director at New World TMT Limited, and Director of New Legend Group Ltd. He is the founder of LifeTech Group, the World Eye Organization, and the Hong Kong Institute of Biotechnology. He has also served as Independent Non-Executive Director of International Business Settlement Holdings Limited.
Dr. Lam obtained his B.S. in Mathematics from Lakehead University, M.S. in Theoretical Physics from University of British Columbia, Ph.D. in Medical Biophysics from University of Toronto, and completed a post-doctoral fellowship at Harvard University. He has been on the faculty of Harvard Medical School and Baylor College of Medicine. As a medical scientist, Dr. Lam has published over 100 scientific articles, including over 10 in Nature and Proceedings of the National Academy of Sciences of the United States of America, as well as more than 20 in scientific and artistic books. In 2001, Dr. Lam's Edible Vaccine was named by Massachusetts Institute of Technology as one of the five patents that would transform business and technology and was also named by Time Magazine as one of the ten most important professions in the 21st century. He has also received a Presidential Medal of Merit, the KPMG Peat Marwick's High Tech Entrepreneur of the Year award, the U.S. High Tech Entrepreneur of the Year Award, and the Asia Society Man of the Year award.
“We welcome Dr. Lam to the Dragon Jade family,” commented Dr. Steve Lai, CEO of Dragon Jade. “His expertise in developing innovative medical technologies and his background in leading medical businesses and organizations will help guide us in our growth. We look forward to working with Dr. Lam as we continue to move our business forward.”
About Dragon Jade
Dragon Jade International Limited (OTCQX: DGJI) is a provider of premier products and services serving high net worth and affluent middle class consumers in Greater China. Through its significant international experience and regional network, Dragon Jade is focused on identifying, developing, and marketing products from other countries in order to meet the increasing demand for better health and quality of life in Asia. For more information, please visit www.dragonjade.com.
Safe Harbor Statement
This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as the Company "believes," "expects," "anticipates," "foresees," "estimates," or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions, or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
Contacts:
Investor Relations:
Rose Zu
ICR Inc
(+1) 646-405-4796
Rose.Zu@icrinc.com
Media:
Corporate Relations Department
Dragon Jade International
info@dgjigroup.com
(+852) 2695-6999